首页> 外文期刊>JMIR public health and surveillance. >HIV Care and Viral Suppression During the Last Year of Life: A Comparison of HIV-Infected Persons Who Died of HIV-Attributable Causes With Persons Who Died of Other Causes in 2012 in 13 US Jurisdictions
【24h】

HIV Care and Viral Suppression During the Last Year of Life: A Comparison of HIV-Infected Persons Who Died of HIV-Attributable Causes With Persons Who Died of Other Causes in 2012 in 13 US Jurisdictions

机译:生命的最后一年中的HIV护理和病毒抑制:2012年美国13个辖区中死于HIV引起原因的死于HIV的感染者与死于其他原因的死者的比较

获取原文
           

摘要

Background: Little information is available about care before death among human immunodeficiency virus (HIV)–infected persons who die of HIV infection, compared with those who die of other causes. Objective: The objective of our study was to compare HIV care and outcome before death among persons with HIV who died of HIV-attributable versus other causes. Methods: We used National HIV Surveillance System data on CD4 T-lymphocyte counts and viral loads within 12 months before death in 2012, as well as on underlying cause of death. Deaths were classified as “HIV-attributable” if the reported underlying cause was HIV infection, an AIDS-defining disease, or immunodeficiency and as attributable to “other causes” if the cause was anything else. Persons were classified as “in continuous care” if they had ≥2 CD4 or viral load test results ≥3 months apart in those 12 months and as having “viral suppression” if their last viral load was 200 copies/mL. Results: Among persons dying of HIV-attributable or other causes, respectively, 65.28% (2104/3223) and 30.88% (1041/3371) met AIDS criteria within 12 months before death, and 33.76% (1088/3223) and 50.96% (1718/3371) had viral suppression. The percentage of persons who received ≥2 tests ≥3 months apart did not differ by cause of death. Prevalence of viral suppression for persons who ever had AIDS was lower among those who died of HIV but did not differ by cause for those who never had AIDS. Conclusions: The lower prevalence of viral suppression among persons who died of HIV than among those who died of other causes implies a need to improve viral suppression strategies to reduce mortality due to HIV infection.
机译:背景:与死于其他原因的人相比,在死于HIV的人免疫缺陷病毒感染者中,死前护理方面的信息很少。目的:我们研究的目的是比较死于艾滋病毒与其他原因的艾滋病毒感染者之间的艾滋病毒护理和死亡前结局。方法:我们使用国家艾滋病毒监测系统的数据,对2012年死亡前12个月内CD4 T淋巴细胞计数和病毒载量以及潜在的死因进行了分析。如果报告的根本原因是艾滋病毒感染,定义艾滋病的疾病或免疫缺陷,则死亡归为“艾滋病毒可归因”,如果原因是其他原因,则归为“其他原因”。如果在这12个月中相隔≥2个CD4或病毒载量测试结果≥3个月,则被分类为“持续护理”;如果最后一次病毒载量小于200个拷贝/ mL,则被分类为“病毒抑制”。结果:在死于艾滋病毒或其他原因的人中,分别有65.28%(2104/3223)和30.88%(1041/3371)在死前12个月内达到艾滋病标准,分别为33.76%(1088/3223)和50.96% (1718/3371)有病毒抑制作用。间隔≥3个月接受≥2次检查的人的百分比没有因死亡原因而不同。艾滋病毒感染者中病毒抑制的患病率较低,但从未感染艾滋病毒的人因病而异。结论:死于艾滋病毒的人中病毒抑制的患病率低于死于其他原因的人,这意味着需要改进病毒抑制策略以降低因感染艾滋病毒而导致的死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号